Human clinical trial of 'Covaxin' starts in Odisha
Bhubaneswar: The human clinical trial of India's first possible anti-Covid vaccine 'Covaxin' began at an institute here on Monday, an official said. The human trial of the coronavirus vaccine has begun at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar. Covaxin has been administered to several volunteers, informed E.Venkat Rao, Principal Investigator of the trial...
Bhubaneswar: The human clinical trial of India's first possible anti-Covid vaccine 'Covaxin' began at an institute here on Monday, an official said.
The human trial of the coronavirus vaccine has begun at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar.
Covaxin has been administered to several volunteers, informed E.Venkat Rao, Principal Investigator of the trial process.
The volunteers went under a thorough screening procedure and several tests, he added.
SUM Hospital is one of the 12 centres selected by Indian Council of Medical Research (ICMR) for conducting phase one and two of the process.
Covaxin is being developed by Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV).
IMS and SUM Hospital is the only medical institute in Odisha which is conducting clinical trial of the vaccine.
Disclaimer :- This story, apart from the heading, has not been edited by Medical Dialogues Team and is auto-generated from news agency feeds. Source: IANS
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd